Lynn C. Swann - 24 May 2023 Form 4 Insider Report for Xylem Inc. (XYL)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
26 May 2023, 17:34:28 UTC
Prior SEC filing
10 May 2023
Next SEC filing
14 May 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Callie Plant, by power of attorney for Lynn C. Swann

Key filing fact

Lynn C. Swann filed Form 4 for Xylem Inc. (XYL) on 26 May 2023.

Key facts

  • This page summarizes Lynn C. Swann's Form 4 filing for Xylem Inc. (XYL).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 26 May 2023, 17:34.

Change

  • Previous filing in this sequence was filed on 10 May 2023.
  • Current net transaction value: +$165,031.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XYL transaction

Common Stock

Award

Transaction value
$165,031
Shares
+1,633
Change %
Price
$101.06
Shares after
1,633
Date
24 May 2023
Ownership
Direct
Footnotes
F1
XYL transaction

Common Stock

Award

Transaction value
$0
Shares
+16,997
Change %
+1041%
Price
$0.000000
Shares after
18,630
Date
24 May 2023
Ownership
Direct
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) and sub-pool of shares from the Evoqua Water Technologies 2017 Equity Plan assumed by Xylem Inc. as part of the merger of Xylem Inc. and Evoqua Water Technologies Corp. ("Evoqua") on May 24, 2023 (the "Merger"), that are scheduled to vest in full on the trading day prior to the 2024 Annual Meeting of Shareholders.

Footnote F2

Received in exchange for 35,418 shares of Evoqua common stock in connection with the Merger. On May 24, 2023, the effective date of the Merger, the closing price of Evoqua's common stock was $49.88 per share, and the closing price of Xylem Inc.'s common stock was $101.06 per share.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .